Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Capsaicin Versus Diclofenac for Chronic Temporomandibular Joint-Related Pain
NCT07598994Completed
- Sponsor
- Istanbul University
- Start
- Aug 2025
- Primary completion
- Apr 2026
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of capsaicin 8% patch in temporomandibular disorders (TMD) and temporomandibular disorder (TMD) (2 arms), sponsored by Istanbul University. Primary endpoint: Visual Analog Scale at 1 Month. Started Aug 2025; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
temporomandibular disorders (TMD)temporomandibular disorder (TMD)
Beyond the preview
Go deeper on NCT07598994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07598994.